Supplemental figure shows IGM-7354 enhances cytotoxicity of NK and CD8+ T cells against tumor cells, implying potential in cancer immunotherapy.
Supplemental Figure 6. IGM-7354 promotes the killing of MDA-MB-231 tumor cells in vitro and preferentially modulates CD8+ T cells.
No takes yet. Share an insight, caveat, or question.
Desbois et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: